Referencias bibliográficas

EXPLORANDO LOS BENEFICIOS DEL ÁCIDO DOCOSAHEXANOICO EN LA SALUD HUMANA

  1. Rustan, A. C., & Drevon, C. A. Fatty acids: structures and properties. Enciclopedia of Life Sciences. 2001.
  2. Djuricic, I., Calder, P. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients 2021, 13, 2421.
  3. Simopoulos A. P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 2002, 56 (8), 365 – 379.
  4. Saini, R. K., & Keum, Y. S. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance—A review. Life sciences, 2018, 203, 255-267.
  5. Aterburn-LM et al. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr, 2006, 83 (suppl), 1467S – 1476S.
  6. John H. Lee.et al. Omega-3 Fatty Acids for Cardioprotection. Mayo Clin Proc. 2008, 83 (3), 324-332.
  7. Harris, W. S. The omega-3 index as a risk factor for coronary heart disease. The American journal of clinical nutrition, 2008, 87 (6), 1997S-2002S.
  8. Allairea, J. et. al. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid. Prostaglandins, Leukot, Essent. Fatty Acids, 2017, 120, 8–14.
  9. Innes J.K. et al. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review. Int. J. Mol. Sci. 2018, 19, 532-524.
  10. Bazan, N. G. Neuroprotectin D1 (NPD1): a DHA‐derived mediator that protects brain and retina against cell injury‐induced oxidative stress. Brain pathology, 2005, 15 (2), 159-166.
  11. Akabas S, Deckelbaum R. N-3 fatty acids: recommendations for therapeutic and prevention. Am. J. Clin. Nutr. 2006, 83, 1451-1462.
  12. Sanhueza, J., Nieto, S., & Valenzuela, A. Ácido docosahexaenoico (DHA), desarrollo cerebral, memoria y aprendizaje: la importancia de la suplementación perinatal. Revista chilena de nutrición, 2004, 31 (2), 84-92.
  13. Nicolas G. Bazan et al. Omega-3 Essential Fatty Acids Modulate Initiation and Progression of Neurodegenerative Disease. Mol. Neurobiol. 2010, 41, 367–374.
  14. Bazan N.G. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer’s disease models. PLoS One. 2011, 6 (1), 15816.

    Bazan N.G. et al.  Annual Review of Nutrition. 2011, 31, 321-351.

  15. Johnson, E. J., & Schaefer, E. J. Potential role of dietary n− 3 fatty acids in the prevention of dementia and macular degeneration. The American journal of clinical nutrition, 2015, 83 (6), 1494S-1498S.

    Desmettre T, Lecerf JM, Souied EH. Nutrition and age-related macular degeneration. J. Fr. Ophtalmol. 2004 27 (9), 3S38-3S56.

  16. Safarinejad M.R., Hosseini S.Y., Dadkhah F., Asgari M.A. Relationship of omega-3 and omega-6 fatty acids with semen characteristics, and anti-oxidant status of seminal plasma: a comparison between fertile and infertile men. Clin. Nutr. 2010, 29 (1),100-105.
  17. Stanhiser J., Jukic A.M.Z., Mc Connaughey D.R, Steiner A.Z. Omega-3 fatty acid supplementation and fecundability. Hum Reprod. 2022, 37 (5), 1037-1046.
  18. International Fish Oil Standards (IFOS TM) https://www.Nutrasource.ca/certifications-by-nutrasource/international-fish-oil-standards-ifos/